Brain Metastasis: Clinical Implications of Branched Evolution

Area of Science:

• Neuro-oncology
• Cancer Genomics
• Translational Medicine

Background:

• Brain metastases (BM) represent the most frequent adult intracranial tumors.
• Genomic understanding has shifted cancer treatment from chemotherapy to genotype-guided approaches, improving outcomes.
• Despite advances, BM progression remains a significant clinical challenge.

Purpose of the Study:

• To review the current understanding of intermetastatic genomic heterogeneity in BM.
• To summarize the spectrum of genetic alterations observed in BM.
• To discuss how molecular profiling of BM can refine therapeutic strategies and improve patient outcomes.

Main Methods:

• Literature review and synthesis of current research on BM genomics.
• Analysis of genetic alterations across different BM.
• Discussion of therapeutic implications of molecular profiling.

Main Results:

• Significant intermetastatic genomic heterogeneity exists within BM.
• A wide spectrum of genetic alterations has been identified in BM.
• Molecular profiling reveals opportunities for targeted therapies.

Conclusions:

• Understanding BM genomic heterogeneity is crucial for effective treatment.
• Molecular profiling of BM can guide personalized therapeutic strategies.
• Refined strategies may minimize BM progression morbidity and improve patient survival.